The international BIO convention is all about seduction. All fifty states sent representatives to Philly this week to make the case that their state was the best for biotech. Seventy countries were there touting their awesome awesomeness.
Does all this seduction really work?
A new class of drugs for cardiovascular disease was reviewed recently at the FDA. Will they become blockbusters like Pfizer’s Lipitor?
Join us for today’s Gene and Tonic where we also review a class of drug that works similar to the cholesterol lowering statins but has never been tested in clinical trials.